Federal award (DEFINITIVE CONTRACT, fiscal year 2022)
Recipient: VIRGINIA COMMONWEALTH UNIVERSITY
Awarding agency: Department of Health and Human Services / Food and Drug Administration
Funding agency: Department of Health and Human Services / Food and Drug Administration
Period of performance: 2023-09-21 to 2024-09-20
Current total value of award: $552931
Description: IN VITRO AND IN VIVO ASSESSMENT OF BUPRENORPHINE EXTENDED RELEASE INJECTIONS FOR GENERIC PRODUCT EQUIVALENCE